The United States Drug Enforcement Agency (DEA) has just bypassed two separate opportunities to remove marijuana from schedule 1 of the Controlled Substance Act (CSA) just as the American Epilepsy Society has announced that cannabis extracts completely obliterate seizures in children. At what point does the mounting medical evidence convince the DEA to give up its ludicrous ‘war against drugs’?

reefer-madness-copy

It isn’t likely that the DEA will be swayed. On August 11, 2016 the DEA turned down two petitions. One was from the governors of Rhode Island and Washington, and the other from a resident of New Mexico. Both petitions requested that marijuana be removed from Schedule I of the Controlled Substance Act. If that had transpired, additional research could have proven just how miraculously healing this plant truly is – adding to the mounds of scientific data which has already done so.

Despite evidence that comes from credible scientific bodies, such as the American Epilepsy Society, the DEA instead has declared that marijuana has “no currently accepted medical use and a high potential for abuse,” keeping it in a category of drugs such as heroin, LSD, and ecstasy. It stands to note that ‘legal’ pharmaceutical drugs are of much more concern lately.

The DEA’s dire warnings of ‘reefer madness’ continue while hundreds of peer-reviewed studies suggest cannabis and its natural extracts can heal everything from Cancer to HIV, and yes, epilepsy.

AES states simply about their position on marijuana,

“AES calls on government and private funders to support well-designed clinical research into all promising treatments for epilepsy. To increase clinical research into the effectiveness and safety of marijuana as a possible treatment for resistant epilepsy, the American Epilepsy Society urges that marijuana’s status as a Federal DEA Schedule 1 controlled substance be reviewed. AES’s call for rescheduling is not an endorsement of the legalization of marijuana, but is a recognition that the current restrictions on the use of medical marijuana for research continue to stand in the way of scientifically rigorous research into the development of cannabinoid-based treatments.”

The medical charity, located in Illinois, announced at an annual meeting that in one of the largest studies ever conducted on the topic which they supervised, researchers confirmed that marijuana effectively cures seizures, especially in children.

The study proved that a non-psychoactive extract of cannabis known as Cannabidiol (CBD) provides seizure relief with astounding efficiency.

The study involved 261 patients who received CBD treatment. More than 45% of the children treated experienced a significant reduction in the frequency of seizures, while the seizures were completely cured in 9% of them after 3-month’s use of CBD. More positive results were observed even after the study commenced.

Some children were completely seizure free after CBD treatments.

Dr. Orrin Devinsky, the lead author of the study, stated:

“In the subsequent periods, which are very encouraging, 9 percent of all patients and 13 percent of those with Dravet Syndrome epilepsy were seizure-free. Many have never been seizure-free before.”

How many children will continue to suffer while the DEA stands in obstinate defiance against medical research? As it is just one of four industries that gets rich off of the supposed drug war, it likely won’t change its stance anytime soon.

Image credit: gstatic, featured image: Jonathan Wiggs/The Boston Globe via Getty Images